Personalizing medicine in inflammatory bowel disease-current opinion and future perspectives

Laurent Peyrin-Biroulet   

An update of optimized condition of fecal microbiota transplantation for inflammatory bowel disease

Faming Zhang   

Therapeutic choice for extraintestinal manifestations in ulcerative colitis

Yufang Wang   

*Capsule endoscopy based monitoring of Crohn’s disease: Implication for tight control and treat-to-target

Shomron Ben-Horin   

Are second-line biologics exempt from the TDM requirement?

Jun Shen   

Stem cells as potential therapeutic approaches for inflammatory bowel disease

Shenghong Zhang